References
- Cai X, Jin S, Liu X, et al. Molecular genetic analysis of ABO blood group variations reveals 29 novel ABO subgroup alleles. Transfusion 2013;53:2910–6.
- Vege S, Lomas-Francis C, Aeschlimann J, et al. Three novel ABO alleles and associated serologic phenotypes give insights for bioinformatics and NGS. Transfusion 2017;57(Suppl 3):44A(C52-A03H).
- Sano R, Nakajima T, Takahashi Y, et al. Expression of ABO blood-group genes is dependent upon an erythroid cell– specific regulatory element that is deleted in persons with the Bm phenotype. Blood 2012;119:5301–10.
- Nakajima T, Sano R, Takahashi Y, et al. Mutation of the GATA site in the erythroid cell–specific regulatory element of the ABO gene in a Bm subgroup individual. Transfusion 2013;53: 2917–27.
- Takahashi Y, Isa K, Sano R, et al. Deletion of the RUNX1 binding site in the erythroid cell-specific regulatory element of the ABO gene in two individuals with the Am phenotype. Vox Sang 2014;106:167–75.
- Takahashi Y, Isa K, Sano R, et al. Presence of nucleotide substitutions in transcriptional regulatory elements such as the erythroid cell-specific enhancer-like element and the ABO promoter in individuals with phenotypes A3 and B3, respectively. Vox Sang 2014;107:171–80.
- Sano R, Kuboya E, Nakajima T, et al. A 3.0-kb deletion including an erythroid cell-specific regulatory element in intron 1 of the ABO blood group gene in an individual with the Bm phenotype. Vox Sang 2015;108:310–3.
- Oda A, Isa K, Ogasawara K, et al. A novel mutation of the GATA site in the erythroid cell specific regulatory element of the ABO gene in a blood donor with the AmB phenotype. Vox Sang 2015;108:425–7.
- Tao C, Xiao J, Hu Y, et al. A novel B allele with c.28+5885C>T substitution in the erythroid cell–specific regulatory element identified in an individual with phenotype B3. Transfusion 2017;57:1318–9.
- Ogasawara K, Miyazaki T, Ito S, et al. The B allele with a 5.8 kb deletion in intron 1 of the ABO gene is the major allele in Japanese individuals with Bm and A1Bm phenotypes. Vox Sang 2018;113:393–6.
- Ying Y, Hong X, Xu X, et al. A novel mutation +5904 C>T of RUNX1 site in the erythroid cell-specific regulatory element decreases the ABO antigen expression in Chinese population. Vox Sang 2018;113:594–600.
- Wu PC, Lin Y-H, Tsai LF, et al. ABO genotyping with next-generation sequencing to resolve heterogeneity in donors with serology discrepancies. Transfusion 2018;58:2232–42.
- Ouellette K, Stephanie K, Sweeney J. Adsorption-elution in a weak B subgroup due to a polymorphism in the enhancer region of intron 1 of the B allele. Transfusion 2018;58(Suppl S2):194A(IGT86).
- Hult AK, Hellberg A, Hosseini-Maaf B, et al. Disrupted RUNX1 motifs in the ABO gene explain samples with A3 and B3 phenotypes. Vox Sang 2020;115(Suppl 1):15(3A-S04-03).
- Stef M, Fennell K, Apraiz I, et al. RH genotyping by nonspecific quantitative next-generation sequencing. Transfusion 2020; 60:2691–701.
- Thuresson B, Hellberg A, Olsson ML. Disruption of a binding site for the erythroid transcription factor GATA-1 in intron 1 of the ABO gene in Am and Bm subgroup samples. Vox Sang 2013;105(Suppl 1):44(3C-S22-04).
- JASPAR. A database of transcription factor binding profiles. Available from http://jaspar.genereg.net/. Accessed 20 January 2021.